✦ LIBER ✦

Vascular-targeted therapies for Duchenne muscular dystrophy

✍ Scribed by James P Ennen, Mayank Verma, Atsushi Asakura

Book ID: 120723457
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 307 KB
Volume: 3
Category: Article
ISSN: 2044-5040
DOI: 10.1186/2044-5040-3-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel therapies for Duchenne muscular dy

Novel therapies for Duchenne muscular dystrophy

✍ Robert Kapsa; Andrew J Kornberg; Edward Byrne 📂 Article 📅 2003 🏛 The Lancet 🌐 English ⚖ 304 KB

Utrophin therapy for Duchenne muscular d

Utrophin therapy for Duchenne muscular dystrophy?

✍ Roxanne Nelson 📂 Article 📅 2004 🏛 The Lancet 🌐 English ⚖ 21 KB

Gene therapy for Duchenne muscular dystr

Gene therapy for Duchenne muscular dystrophy

📂 Article 📅 1998 🏛 Adis International Limited (now part of Wolters Kl ⚖ 136 KB

Progress in therapy for Duchenne muscula

Progress in therapy for Duchenne muscular dystrophy

✍ Rebecca J. Fairclough; Akshay Bareja; Kay E. Davies 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 341 KB

Cell based therapy for duchenne muscular

Cell based therapy for duchenne muscular dystrophy

✍ Andrea Farini; Paola Razini; Silvia Erratico; Yvan Torrente; Mirella Meregalli 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

## Abstract Mutations in the dystrophin gene cause an X‐linked genetic disorder: Duchenne muscular dystrophy (DMD). Stem cell therapy is an attractive method to treat DMD because a small number of cells are required to obtain a therapeutic effect. Here, we discussed about multiple types of myogenic

Adenoviral gene therapy for duchenne mus

Adenoviral gene therapy for duchenne muscular dystrophy

✍ Paula R. Clemens; Stefan Kochanek; Suzanne Chan; Frank L. Graham; C. Thomas Cask 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 105 KB